hsa-miR-223-3p

ncRNA information

ncRNA name

hsa-miR-223-3p

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Prognosis

Upstream regulatory factors

Not available

Downstream target

Not available

Cancer information

Cancer name

Head And Neck Squamous Cell Carcinoma

Cancer site

Head, Neck

Treatment information

Treatment type

Chemotherapy

Drug

Cetuximab

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma.

Tissue resource

head and neck squamous cell carcinoma tissues

human head and neck cancer cell lines CAL27

Experiment

qRT-PCR


Institute

Pasteur Hospital

American Type Culture Collection

Country

France

USA

Continent

Europea

Amercia